Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Latest filing published 13 Mar 2025 for 2seventy bio, Inc., €27.1M. Read the official filing
Filing timeline
BuySaleKynam Global Healthcare Master Fund, LP
Insider track record
Disclosed buys
1
Disclosed sells
1
Signal history
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Kynam Global Healthcare Master Fund, LP: trading record in brief
All filings by Kynam Global Healthcare Master Fund, LP on record concern 2seventy bio, Inc. We count 2 filings; the first trade dates from 10 August 2023 and the latest from 11 March 2025.
The open-market side counts 1 purchase for €968k alongside 1 sale for €27.1M. Sales outweigh purchases by €26.1M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2025 alone, the filings show no purchases and 1 sale.
On 13 March 2025 came the latest disclosure, an open-market sale for €27.1M in 2seventy bio, Inc. The most recent open-market purchase was published on 16 August 2023, 1,159 days ago. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Kynam Global Healthcare Master Fund, LP
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
5,953,825 shares@ US$4.9396.5% of flowCommon Stock, par value $0.0001 per shareSEC:0000919574-25-001923:0
▲
Same trade as the filing by Kynam Capital Management, LP, counted once · View ↗
179,000 shares@ US$5.943.5% of flowCommon Stock, par value $0.0001 per shareSEC:0000919574-23-004866:0
Canonical exit: 8 Nov 2023 (T+90)
2 of 1 declaration
